Prevalence and risk factors of lung nodules in a non-smoking Chinese population: a prospective study of low-dose computed tomography screening.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 3/4)
유사 논문P · Population 대상 환자/모집단
271 participants, lung nodules were detected in 40.
I · Intervention 중재 / 시술
LDCT screening at the National Cancer Center of China between January 2006 and December 2023
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
SHS has emerged as a significant risk factor for both lung and clinically relevant nodules. These findings highlight the importance of refining LDCT screening strategies and risk models for non-smoking populations in Asia.
[BACKGROUND] Low-dose computed tomography (LDCT) has significantly improved early detection of lung cancer, especially among high-risk populations.
- 95% CI 1.49-1.70
APA
Tang W, Tang Y, et al. (2026). Prevalence and risk factors of lung nodules in a non-smoking Chinese population: a prospective study of low-dose computed tomography screening.. BMC pulmonary medicine, 26(1). https://doi.org/10.1186/s12890-026-04108-2
MLA
Tang W, et al.. "Prevalence and risk factors of lung nodules in a non-smoking Chinese population: a prospective study of low-dose computed tomography screening.." BMC pulmonary medicine, vol. 26, no. 1, 2026.
PMID
41782100
Abstract
[BACKGROUND] Low-dose computed tomography (LDCT) has significantly improved early detection of lung cancer, especially among high-risk populations. However, the risk factors and lung nodule distributions in non-smoking populations remain underexplored, particularly in Asia. Therefore, in this study, we aimed to explore the risk factors and delineate the detection rate, including lung nodule distributions discovered using LDCT, in a non-smoking Chinese population.
[METHODS] This prospective, single-center study included asymptomatic adults who underwent LDCT screening at the National Cancer Center of China between January 2006 and December 2023. Lung nodules were defined as at least one non-calcified nodule, while clinically relevant lung nodules were defined as at least one solid or partially solid nodule, or at least one non-solid nodule. Multivariate logistic regression models were employed to identify risk factors associated with lung nodules. The outcomes included detection rates and distribution of both nodule types.
[RESULTS] Of 23,271 participants, lung nodules were detected in 40.1% (9,342/23,271); 4.4% (1,023/23,271) had clinically relevant lung nodules. Risk factors for lung nodule development included female sex (odds ratio [OR] 1.12, 95% confidence interval [CI] 1.06-1.19), SHS exposure (OR 1.59, 95% CI 1.49-1.70), and emphysema (OR 1.49, 95% CI 1.24-1.78). The incidence of lung nodules increased with age, peaking at 70-74 years (OR 3.10, 95% CI 2.53-3.79). Risk factors for clinically relevant lung nodules included increasing age, SHS exposure (OR 1.44, 95% CI 1.22-1.69), and emphysema (OR 1.84, 95% CI 1.36-2.49). Detection rates for both nodule types were positively correlated with age (lung nodules: women 33.7-61.4%, men 32.3-57.5%; clinically relevant lung nodules: women 2.4-12.4%, men 2.2-15.1%).
[CONCLUSIONS] This real-world study of a non-smoking Chinese population revealed high lung nodule detection rates, with women exhibiting a higher detection rate than men. SHS has emerged as a significant risk factor for both lung and clinically relevant nodules. These findings highlight the importance of refining LDCT screening strategies and risk models for non-smoking populations in Asia.
[METHODS] This prospective, single-center study included asymptomatic adults who underwent LDCT screening at the National Cancer Center of China between January 2006 and December 2023. Lung nodules were defined as at least one non-calcified nodule, while clinically relevant lung nodules were defined as at least one solid or partially solid nodule, or at least one non-solid nodule. Multivariate logistic regression models were employed to identify risk factors associated with lung nodules. The outcomes included detection rates and distribution of both nodule types.
[RESULTS] Of 23,271 participants, lung nodules were detected in 40.1% (9,342/23,271); 4.4% (1,023/23,271) had clinically relevant lung nodules. Risk factors for lung nodule development included female sex (odds ratio [OR] 1.12, 95% confidence interval [CI] 1.06-1.19), SHS exposure (OR 1.59, 95% CI 1.49-1.70), and emphysema (OR 1.49, 95% CI 1.24-1.78). The incidence of lung nodules increased with age, peaking at 70-74 years (OR 3.10, 95% CI 2.53-3.79). Risk factors for clinically relevant lung nodules included increasing age, SHS exposure (OR 1.44, 95% CI 1.22-1.69), and emphysema (OR 1.84, 95% CI 1.36-2.49). Detection rates for both nodule types were positively correlated with age (lung nodules: women 33.7-61.4%, men 32.3-57.5%; clinically relevant lung nodules: women 2.4-12.4%, men 2.2-15.1%).
[CONCLUSIONS] This real-world study of a non-smoking Chinese population revealed high lung nodule detection rates, with women exhibiting a higher detection rate than men. SHS has emerged as a significant risk factor for both lung and clinically relevant nodules. These findings highlight the importance of refining LDCT screening strategies and risk models for non-smoking populations in Asia.
MeSH Terms
Humans; Female; Male; Middle Aged; Prospective Studies; China; Risk Factors; Tomography, X-Ray Computed; Aged; Lung Neoplasms; Prevalence; Early Detection of Cancer; Solitary Pulmonary Nodule; Multiple Pulmonary Nodules; Adult; Non-Smokers; Sex Factors; Logistic Models; East Asian People
같은 제1저자의 인용 많은 논문 (5)
- Potential of small-molecule targeted drugs in combination with CAR-T cell therapy for hematologic lymphomas.
- Radiation-induced acquired expression of PD-L1 and reprogramming of the tumor microenvironment in cervical cancer.
- Efficacy and safety of SHR-1701 combined with chemoradiotherapy as neoadjuvant treatment for locally advanced rectal cancer.
- Identification of RCN3-positive cancer-associated fibroblasts as novel drivers of colorectal cancer through a TGF-β pathway-based risk signature.
- Coronavirus disease 2019 infection reduces EGFR-TKI efficacy in non-small cell lung carcinoma: Real-world evidence from a multicenter propensity-matched cohort.